Finally, the role of the PINK1/Parkin pathway in cancer onset and progression has already been extensively reviewed (Lu et al., 2013; Matsuda et al., 2015; Eid and Kondo, 2017; Palikaras et al., 2017). The gene discussed is PRKN; the disease is cancer.